Convergent Finance completed the acquisition of a 43.7% stake in Jagsonpal Pharmaceuticals for $36m.

Convergent Finance, an investment company, completed the acquisition of a 43.7% stake in Jagsonpal Pharmaceuticals, a provider of bulk drugs and pharmaceutical formulations, for $36m. "Jagsonpal is a well-established company in the Indian domestic formulations industry with a strong portfolio of brands. Women's health is a critical issue for our nation, and Jagsonpal plays an important role in making its products accessible to the masses. The company has a robust distribution network and large field force of medical representatives. We are honoured and excited to work with the Kochhar family and Jagsonpal's management team to identify growth levers that can catapult its market position," Harsha Raghavan, Convergent Managing Partner.